The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View gvhd content recommended for you
Co-occurrence of inflammation and fibrosis in cGvHD
Question 1 / 1
Chronic GvHD can result in inflammation and tissue damage. Which cells are recruited from the blood by chemokines and cause cytolytic damage to tissues?
A
Th1 and Th17 cells
B
Th2 cells
C
Tc1 cells
D
Treg and Th2 cells
⭐GvHD Hub spotlight: Inflammation and fibrosis in cGvHD⭐
Inflammation in chronic graft-versus-host disease (GvHD) can occur alongside fibrotic manifestations, which can severely impact quality of life. Belumosudil, a ROCK2 inhibitor, has shown efficacy in treating a chronic GvHD patient population with fibrotic manifestations and multiple organ involvement.
This educational resource is independently supported by Sanofi. All content was developed by SES in collaboration with an expert steering committee; funders were allowed no influence on the content of this resource.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
